<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:epub="http://www.idpf.org/2007/ops" lang="en">
<head>
<meta http-equiv="default-style" content="application/xhtml+xml; charset=utf-8"/>
<title>Brunner &#38; Suddarth&#8217;s Textbook of Medical-Surgical Nursing, 15e</title>
<link rel="stylesheet" type="text/css" href="style.css"/>
</head>
<body epub:type="bodymatter">
<div id="main_container">
<section epub:type="division">
<h4 class="h4" id="s1186">THROMBOTIC DISORDERS</h4>
<p class="nonindent">Several conditions can affect the balance of normal hemostasis, causing excessive thrombosis that can alter arterial or venous circulation. Arterial thrombosis is caused by platelet aggregation, while venous thrombosis is a result of accumulation of platelets, red blood cells, and thrombin. Abnormalities that predispose a person to thrombotic events include decreased clotting inhibitors in the circulation, impaired liver function, lack of fibrinolytic enzymes, and vascular abnormalities that promote platelet aggregation. Thrombosis may also occur as the initial manifestation of an occult malignancy or as a complication of a previously diagnosed cancer. In some cases, more than one precipitating factor exists. There are several inherited or acquired disorders, including hyperhomocysteinemia, antithrombin (AT) deficiency, protein C deficiency, protein S deficiency, activated protein C (APC) resistance, and factor V Leiden deficiency that can predispose patients to repeated episodes of thrombosis. These are also referred to as hypercoagulable states or thrombophilia. Inherited disorders should prompt a referral for familial genetic testing. Genetic testing is not indicated with acquired disorders.</p>
<div class="pagebreak_container"><span class="pagebreak">p. 942</span><div class="rule"></div><span id="page943" class="pagebreak" epub:type="pagebreak" title="943">p. 943</span></div>
<div class="box5a">
<p class="Box5pNumber" id="ct29-11"><strong>Chart 29-11 <img class="m" src="images/planofnursingcare.png" alt=""/> PLAN OF NURSING CARE</strong></p>
</div>
<div class="box5">
<p class="Box5pTitle"><strong>The Patient with Disseminated Intravascular Coagulation</strong></p>
</div>
<table class="table5">
<tr>
<td colspan="3" class="td4">
<p class="BX5MTXT1"><strong><button class="vsm-bubble-widget glossary-term" data-bubble-content="&lt;b&gt;nursing diagnosis:&lt;/b&gt; a clinical judgment concerning a person&#x2019;s, family&#x2019;s, or community&#x2019;s actual or potential health problems, state of health promotion, or potential risk that can be managed by independent nursing interventions">NURSING DIAGNOSIS:</button></strong> Risk for hypovolaemia associated with bleeding</p>
<p class="BX5MTXT1"><strong>GOAL:</strong> Hemodynamic status maintained; urine output &#x2265;0.5 mL/kg/h over 6 hours or &#x003C;400 mL in 24 hours</p></td>
</tr>
<tr>
<td class="td3"><p class="BX5MUNTMT2"><strong>Nursing Interventions</strong></p></td>
<td class="td3"><p class="BX5MUNTMT2"><strong>Rationale</strong></p></td>
<td class="td3"><p class="BX5MUNTMT2"><strong>Expected Outcomes</strong></p></td>
</tr>
<tr>
<td class="td3a">
<p class="Box5TABLEpNL1First"><span class="numah">1.</span>Avoid procedures/activities that can increase intracranial pressure (e.g., coughing, straining to have a bowel movement).</p>
<p class="Box5TABLEpNL1Middle"><span class="numah">2.</span>Monitor vital signs closely, including neurologic checks:</p>
<p class="Box5TABLEpNL2Middle"><span class="numah">a.</span>Monitor hemodynamics.</p>
<p class="Box5TABLEpNL2Middle"><span class="numah">b.</span>Monitor abdominal girth.</p>
<p class="Box5TABLEpNL2Middle"><span class="numah">c.</span>Monitor urine output.</p>
<p class="Box5TABLEpNL1Middle"><span class="numah">3.</span>Avoid medications that interfere with platelet function if possible (e.g., aspirin, nonsteroidal anti-inflammatory drugs, beta-lactam antibiotics).</p>
<p class="Box5TABLEpNL1Middle"><span class="numah">4.</span>Avoid rectal probes, rectal medications.</p>
<p class="Box5TABLEpNL1Middle"><span class="numah">5.</span>Avoid intramuscular injections.</p>
<p class="Box5TABLEpNL1Middle"><span class="numah">6.</span>Monitor amount of external bleeding carefully:</p>
<p class="Box5TABLEpNL2Middle"><span class="numah">a.</span>Monitor number of dressings, percentage of dressing saturated; time to saturate a dressing is more objective than &#x201C;dressing saturated a moderate amount.&#x201D;</p>
<p class="Box5TABLEpNL2Middle"><span class="numah">b.</span>Assess suction output, all excreta for frank or occult blood.</p>
<p class="Box5TABLEpNL2Middle"><span class="numah">c.</span>Monitor pad counts in women with vaginal bleeding.</p>
<p class="Box5TABLEpNL2Middle"><span class="numah">d.</span>Women may receive progesterone to prevent menses.</p>
<p class="Box5TABLEpNL1Middle"><span class="numah">7.</span>Use low pressure for any necessary suctioning.</p>
<p class="Box5TABLEpNL1Middle"><span class="numah">8.</span>Administer oral hygiene carefully.</p>
<p class="Box5TABLEpNL2Middle"><span class="numah">a.</span>Avoid lemon-glycerin swabs, hydrogen peroxide, commercial mouthwashes.</p>
<p class="Box5TABLEpNL2Middle"><span class="numah">b.</span>Use sponge-tipped swabs, salt/baking soda (bicarbonate of soda) mouth rinses.</p>
<p class="Box5TABLEpNL1Last"><span class="numah">9.</span>Avoid dislodging any clots, including those around IV sites and injection sites.</p></td>
<td class="td3a">
<p class="Box5TABLEpNL1First"><span class="numah">1.</span>Prevents intracranial bleeding</p>
<p class="white1">&#x00A0;</p>
<p class="white1">&#x00A0;</p>
<p class="Box5TABLEpNL1Middle"><span class="numah">2.</span>Identifies signs of hemorrhage/shock as soon as possible</p>
<p class="white1">&#x00A0;</p>
<p class="white1">&#x00A0;</p>
<p class="white1">&#x00A0;</p>
<p class="Box5TABLEpNL1Middle"><span class="numah">3.</span>Decreases problems with platelet aggregation and adhesion</p>
<p class="white1">&#x00A0;</p>
<p class="white1">&#x00A0;</p>
<p class="Box5TABLEpNL1Middle"><span class="numah">4.</span>Decreases risk of rectal bleeding</p>
<p class="Box5TABLEpNL1Middle"><span class="numah">5.</span>Decreases risk of intramuscular bleeding</p>
<p class="Box5TABLEpNL1Middle"><span class="numah">6.</span></p>
<p class="white1">&#x00A0;</p>
<p class="Box5TABLEpNL2Middle"><span class="numah">a.</span>Provides accurate, objective assessment of extent of bleeding</p>
<p class="white1">&#x00A0;</p>
<p class="white1">&#x00A0;</p>
<p class="Box5TABLEpNL2Middle"><span class="numah">b.</span>Identifies presence of or quantifies extent of bleeding</p>
<p class="Box5TABLEpNL2Middle"><span class="numah">c.</span>Quantifies extent of bleeding</p>
<p class="white1">&#x00A0;</p>
<p class="Box5TABLEpNL2Middle"><span class="numah">d.</span>Decreases risk of bleeding from gynecologic source</p>
<p class="Box5TABLEpNL1Middle"><span class="numah">7.</span>Prevents excessive trauma that can cause additional bleeding</p>
<p class="Box5TABLEpNL1Middle"><span class="numah">8.</span>Prevents excessive trauma that can cause bleeding. Glycerin and alcohol (in commercial mouthwashes) dry the mucosa, increasing risk for bleeding.</p>
<p class="Box5TABLEpNL1Last">&#x00A0;</p>
<p class="Box5TABLEpNL1Last"><span class="numah">9.</span>Reduces risk for excessive bleeding from sites</p></td>
<td class="td3a">
<p class="Box5TABLEpBL1First"><span class="bull1a">&#x2022;</span>Level of consciousness (LOC) stable</p>
<p class="Box5TABLEpBL1Middle"><span class="bull1a">&#x2022;</span>Central venous pressure 5&#x2013;12 cm H<sub>2</sub>O, systolic blood pressure &#x2265;70 mm Hg</p>
<p class="Box5TABLEpBL1Middle"><span class="bull1a">&#x2022;</span>Urine output &#x2265;0.5 mL/kg/h</p>
<p class="Box5TABLEpBL1Middle"><span class="bull1a">&#x2022;</span>Decreased bleeding</p>
<p class="Box5TABLEpBL1Middle"><span class="bull1a">&#x2022;</span>Decreased oozing</p>
<p class="Box5TABLEpBL1Middle"><span class="bull1a">&#x2022;</span>Decreased ecchymoses</p>
<p class="Box5TABLEpBL1Middle"><span class="bull1a">&#x2022;</span>Amenorrhea</p>
<p class="Box5TABLEpBL1Middle"><span class="bull1a">&#x2022;</span>Absence of oral and bronchial bleeding</p>
<p class="Box5TABLEpBL1Last"><span class="bull1a">&#x2022;</span>Oral mucosa clean, moist, intact</p></td>
</tr>
<tr>
<td colspan="3" class="td4">
<p class="BX5MTXT1"><strong><button class="vsm-bubble-widget glossary-term" data-bubble-content="&lt;b&gt;nursing diagnosis:&lt;/b&gt; a clinical judgment concerning a person&#x2019;s, family&#x2019;s, or community&#x2019;s actual or potential health problems, state of health promotion, or potential risk that can be managed by independent nursing interventions">NURSING DIAGNOSIS:</button></strong> Risk for impaired skin integrity associated with ischemia or bleeding</p>
<p class="BX5MTXT1"><strong>GOAL:</strong> Skin integrity remains intact; oral mucosa remains intact</p></td>
</tr>
<tr>
<td class="td3"><p class="BX5MUNTMT2"><strong>Nursing Interventions</strong></p></td>
<td class="td3"><p class="BX5MUNTMT2"><strong>Rationale</strong></p></td>
<td class="td3"><p class="BX5MUNTMT2"><strong>Expected Outcomes</strong></p></td>
</tr>
<tr>
<td class="td3a">
<p class="Box5TABLEpNL1First"><span class="numah">1.</span>Assess skin, with particular attention to bony prominences, skin folds.</p>
<p class="white1">&#x00A0;</p>
<p class="white1">&#x00A0;</p>
<p class="Box5TABLEpNL1Middle"><span class="numah">2.</span>Reposition carefully; use pressure-reducing mattress.</p>
<p class="Box5TABLEpNL1Middle"><span class="numah">3.</span>Perform careful skin care every 2 hours, emphasizing dependent areas, all bony prominences, and perineum.</p>
<p class="Box5TABLEpNL1Middle"><span class="numah">4.</span>Use lamb&#x2019;s wool between digits, around ears, as needed.</p>
<p class="Box5TABLEpNL1Middle"><span class="numah">5.</span>Use prolonged pressure (at least 5 minutes) after injection or procedure when such measures must be performed.</p>
<p class="Box5TABLEpNL1Last"><span class="numah">6.</span>Perform oral hygiene carefully (see previous discussion).</p></td>
<td class="td3a">
<p class="Box5TABLEpNL1First"><span class="numah">1.</span>Prompt identification of any area of risk for skin breakdown or showing early signs of breakdown can prompt early intervention and reduce complications.</p>
<p class="Box5TABLEpNL1First"><span class="numah">2&#x2013;4.</span>&#x00A0;&#x00A0;Meticulous skin care and use of measures to prevent pressure on bony prominences decreases risk of skin trauma.</p>
<p class="Box5TABLEpNL1First">&#x00A0;</p>
<p class="Box5TABLEpNL1First">&#x00A0;</p>
<p class="Box5TABLEpNL1First">&#x00A0;</p>
<p class="Box5TABLEpNL1First">&#x00A0;</p>
<p class="Box5TABLEpNL1First"><span class="numah">5.</span> Initial platelet plug is very unstable and can be easily dislodged, which can lead to increased bleeding.</p>
<p class="Box5TABLEpNL1First"><span class="numah">6.</span> Meticulous care is needed to decrease trauma, bleeding, and risk of infection.</p></td>
<td class="td3a">
<p class="Box5TABLEpBL1First"><span class="bull1a">&#x2022;</span>Skin integrity remains intact; skin is warm, and of normal color.</p>
<p class="Box5TABLEpBL1Last"><span class="bull1a">&#x2022;</span>Oral mucosa is intact, pink, moist, without bleeding.</p></td>
</tr>
<tr>
<td colspan="3" class="td4">
<p class="BX5MTXT1"><span epub:type="pagebreak" id="page944" title="944"></span><strong><button class="vsm-bubble-widget glossary-term" data-bubble-content="&lt;b&gt;nursing diagnosis:&lt;/b&gt; a clinical judgment concerning a person&#x2019;s, family&#x2019;s, or community&#x2019;s actual or potential health problems, state of health promotion, or potential risk that can be managed by independent nursing interventions">NURSING DIAGNOSIS:</button></strong> Fluid imbalance associated with excessive blood and/or factor component replacement</p>
<p class="BX5MTXT1"><strong>GOAL:</strong> Absence of edema; absence of crackles; intake not greater than output</p></td>
</tr>
<tr>
<td class="td3"><p class="BX5MUNTMT2"><strong>Nursing Interventions</strong></p></td>
<td class="td3"><p class="BX5MUNTMT2"><strong>Rationale</strong></p></td>
<td class="td3"><p class="BX5MUNTMT2"><strong>Expected Outcomes</strong></p></td>
</tr>
<tr>
<td class="td3a">
<p class="Box5TABLEpNL1First"><span class="numah">1.</span>Auscultate breath sounds every 2&#x2013;4 hours.</p>
<p class="Box5TABLEpNL1Middle"><span class="numah">2.</span>Monitor extent of edema.</p>
<p class="Box5TABLEpNL1Middle"><span class="numah">3.</span>Monitor volume of IV fluids, blood products; decrease volume of IV medications if indicated.</p>
<p class="Box5TABLEpNL1Last"><span class="numah">4.</span>Administer diuretics as prescribed.</p></td>
<td class="td3a">
<p class="Box5TABLEpNL1First"><span class="numah">1.</span>Crackles can develop quickly.</p>
<p class="Box5TABLEpNL1Middle"><span class="numah">2.</span>Fluid may extend beyond intravascular space.</p>
<p class="Box5TABLEpNL1Middle"><span class="numah">3.</span>Helps prevent fluid overload</p>
<p class="Box5TABLEpNL1Last">&#x00A0;</p>
<p class="Box5TABLEpNL1Last"><span class="numah">4.</span>Decreases excess fluid volume</p></td>
<td class="td3a">
<p class="Box5TABLEpBL1First"><span class="bull1a">&#x2022;</span>Breath sounds clear</p>
<p class="Box5TABLEpBL1Middle"><span class="bull1a">&#x2022;</span>Absence of edema</p>
<p class="Box5TABLEpBL1Middle"><span class="bull1a">&#x2022;</span>Intake does not exceed output</p>
<p class="Box5TABLEpBL1Last"><span class="bull1a">&#x2022;</span>Weight stable</p></td>
</tr>
<tr>
<td colspan="3" class="td4">
<p class="BX5MTXT1"><strong><button class="vsm-bubble-widget glossary-term" data-bubble-content="&lt;b&gt;nursing diagnosis:&lt;/b&gt; a clinical judgment concerning a person&#x2019;s, family&#x2019;s, or community&#x2019;s actual or potential health problems, state of health promotion, or potential risk that can be managed by independent nursing interventions">NURSING DIAGNOSIS:</button></strong> Risk for injury associated with microthrombi</p>
<p class="BX5MTXT1"><strong>GOAL:</strong> Neurologic status remains intact; absence of hypoxemia; peripheral pulses remain intact; skin integrity remains intact; urine output remains &#x2265;0.5 mL/kg/h over 6 hours and &#x003E;400 mL in 24 hours</p></td>
</tr>
<tr>
<td class="td3"><p class="BX5MUNTMT2"><strong>Nursing Interventions</strong></p></td>
<td class="td3"><p class="BX5MUNTMT2"><strong>Rationale</strong></p></td>
<td class="td3"><p class="BX5MUNTMT2"><strong>Expected Outcomes</strong></p></td>
</tr>
<tr>
<td class="td3a">
<p class="Box5TABLEpNL1First"><span class="numah">1.</span>Assess neurologic, pulmonary, integumentary systems.</p>
<p class="Box5TABLEpNL1Middle"><span class="numah">2.</span>Monitor response to heparin therapy.</p>
<p class="white1">&#x00A0;</p>
<p class="white1">&#x00A0;</p>
<p class="Box5TABLEpNL1Middle"><span class="numah">3.</span>Assess extent of bleeding.</p>
<p class="white1">&#x00A0;</p>
<p class="white1">&#x00A0;</p>
<p class="Box5TABLEpNL1Middle"><span class="numah">4.</span>Monitor fibrinogen levels.</p>
<p class="white1">&#x00A0;</p>
<p class="Box5TABLEpNL1Last"><span class="numah">5.</span>Stop aminocaproic acid, if prescribed, if symptoms of thrombosis occur.</p></td>
<td class="td3a">
<p class="Box5TABLEpNL1First"><span class="numah">1.</span>Initial signs of thrombosis may be subtle.</p>
<p class="Box5TABLEpNL1First">&#x00A0;</p>
<p class="Box5TABLEpNL1Middle"><span class="numah">2.</span>Assure anticoagulation effectiveness that may prevent formation of additional thromboses.</p>
<p class="Box5TABLEpNL1Middle"><span class="numah">3.</span>Objective measurements of all sites of bleeding are crucial to accurately assess extent of blood loss.</p>
<p class="Box5TABLEpNL1Middle"><span class="numah">4.</span>Response to heparin is most accurately reflected in fibrinogen level.</p>
<p class="Box5TABLEpNL1Last"><span class="numah">5.</span>Aminocaproic acid should be used only in the setting of extensive hemorrhage not responding to replacement therapy.</p></td>
<td class="td3a">
<p class="Box5TABLEpBL1First"><span class="bull1a">&#x2022;</span>Arterial blood gases, O<sub>2</sub> saturation, pulse oximetry, LOC within normal limits</p>
<p class="Box5TABLEpBL1Middle"><span class="bull1a">&#x2022;</span>Breath sounds clear</p>
<p class="Box5TABLEpBL1Middle"><span class="bull1a">&#x2022;</span>Absence of edema</p>
<p class="Box5TABLEpBL1Middle"><span class="bull1a">&#x2022;</span>Intake does not exceed output</p>
<p class="Box5TABLEpBL1Last"><span class="bull1a">&#x2022;</span>Weight stable</p></td>
</tr>
<tr>
<td colspan="3" class="td4">
<p class="BX5MTXT1"><strong><button class="vsm-bubble-widget glossary-term" data-bubble-content="&lt;b&gt;nursing diagnosis:&lt;/b&gt; a clinical judgment concerning a person&#x2019;s, family&#x2019;s, or community&#x2019;s actual or potential health problems, state of health promotion, or potential risk that can be managed by independent nursing interventions">NURSING DIAGNOSIS:</button></strong> Anxiety associated with uncertain prognosis and risk for death</p>
<p class="BX5MTXT1"><strong>GOAL:</strong> Feelings identified/verbalized; realistic hope maintained</p></td>
</tr>
<tr>
<td class="td3"><p class="BX5MUNTMT2"><strong>Nursing Interventions</strong></p></td>
<td class="td3"><p class="BX5MUNTMT2"><strong>Rationale</strong></p></td>
<td class="td3"><p class="BX5MUNTMT2"><strong>Expected Outcomes</strong></p></td>
</tr>
<tr>
<td class="td3a">
<p class="Box5TABLEpNL1First"><span class="numah">1.</span>Identify previous coping mechanisms, if possible; encourage patient to use them as appropriate.</p>
<p class="Box5TABLEpNL1Middle"><span class="numah">2.</span>Explain all procedures and their rationale in terms that the patient and family/significant others can understand.</p>
<p class="Box5TABLEpNL1Middle"><span class="numah">3.</span>Assist family in supporting patient.</p>
<p class="white1">&#x00A0;</p>
<p class="white1">&#x00A0;</p>
<p class="Box5TABLEpNL1Last"><span class="numah">4.</span>Use services from behavioral health, chaplain as needed.</p></td>
<td class="td3a">
<p class="Box5TABLEpNL1First"><span class="numah">1.</span>Identifying previous stressful situations can aid in recall of successful coping mechanisms.</p>
<p class="Box5TABLEpNL1Middle"><span class="numah">2.</span>Decreased knowledge and uncertainty can increase anxiety.</p>
<p class="white1">&#x00A0;</p>
<p class="Box5TABLEpNL1Middle"><span class="numah">3.</span>Family/significant others can be valuable in assisting the patient to use coping strategies and to maintain hope.</p>
<p class="Box5TABLEpNL1Last"><span class="numah">4.</span>An interdisciplinary approach may be warranted, particularly when coping strategies are maladaptive or ineffective. The spiritual dimension of care may be especially important in a crisis.</p></td>
<td class="td3a">
<p class="Box5TABLEpBL1First"><span class="bull1a">&#x2022;</span>Previously used coping strategies are identified and utilized, to the extent the patient is able to do so.</p>
<p class="Box5TABLEpBL1Last"><span class="bull1a">&#x2022;</span>Patient and family indicate understanding of procedures as situation permits.</p></td>
</tr>
</table>
<p class="BoxpCreditsListPara">LOC, level of consciousness.</p>
<p class="indent1">Thrombotic disorders require anticoagulation therapy; the duration of therapy varies with the location and extent of thrombosis, precipitating events (e.g., trauma, immobility), and any concurrent risk factors (e.g., use of oral contraceptives, obesity, tobacco use, integrity of blood vessels, previous thrombotic events; see <a href="#tt29-6">Table 29-6</a>). Conditions that may result from thrombosis include ACS (see <a href="c23.xhtml">Chapter 23</a>), ischemic stroke (see <a href="c62.xhtml">Chapter 62</a>), and occlusive peripheral arterial disease (see <a href="c26.xhtml">Chapter 26</a>). With some conditions, or with repeated thrombosis, lifelong anticoagulation may be required.</p>
<div class="pagebreak_container"><span class="pagebreak">p. 944</span><div class="rule"></div><span id="page945" class="pagebreak" epub:type="pagebreak" title="945">p. 945</span></div>
<div class="table">
<table class="tbo" id="tt29-6">
<colgroup>
<col style="width:20%"></col>
<col style="width:80%"></col>
</colgroup>
<tr>
<td class="tdnum"><p class="tnum"><strong>TABLE&#x00A0;29-6</strong></p></td>
<td><p class="tcaption"><img src="images/icon50.png" alt=""/> Risk Factors for Thrombosis</p></td>
</tr>
</table>
<table class="table">
<tr>
<td class="thead"><p class="T2">Acquired</p></td>
<td class="thead"><p class="T2">Inherited</p></td>
<td class="thead"><p class="T2">Mixed/Unknown</p></td>
</tr>
<tr>
<td class="td76">
<p class="tbodyleft">Advanced age</p>
<p class="tbodyleft">Antiphospholipid antibody syndrome</p>
<p class="tbodyleft">Atrial fibrillation</p>
<p class="tbodyleft">Diabetes</p>
<p class="tbodyleft">Drugs (e.g., cocaine, ergot)</p>
<p class="tbodyleft">Estrogen therapy</p>
<p class="tbodyleft">Hypertension</p>
<p class="tbodyleft">Inflammatory bowel disease</p>
<p class="tbodyleft">Immobility</p>
<p class="tbodyleft">Lupus anticoagulant</p>
<p class="tbodyleft">Major surgery</p>
<p class="tbodyleft">Myeloproliferative disease</p>
<p class="tbodyleft">Nephrotic syndrome</p>
<p class="tbodyleft">Obesity</p>
<p class="tbodyleft">Paralysis</p>
<p class="tbodyleft">Pregnancy/postpartum period</p>
<p class="tbodyleft">Prior stroke</p>
<p class="tbodyleft">Prior superficial vein thrombosis</p>
<p class="tbodyleft">Smoking</p>
<p class="tbodyleft">Trauma/fracture</p>
<p class="tbodyleft">Vascular access devices</p></td>
<td class="td76">
<p class="tbodyleft">Antithrombin deficiency</p>
<p class="tbodyleft">Factor V Leiden</p>
<p class="tbodyleft">Factor XII deficiency</p>
<p class="tbodyleft">Protein C deficiency</p>
<p class="tbodyleft">Protein S deficiency</p>
<p class="tbodyleft">Prothrombin 20210<sup>a</sup></p></td>
<td class="td76">
<p class="tbodyleft">Activated protein C resistance</p>
<p class="tbodyleft">&#x2191; Factor VII</p>
<p class="tbodyleft">&#x2191; Factor VIII</p>
<p class="tbodyleft">&#x2191; Factor IX</p>
<p class="tbodyleft">&#x2191; Factor XI</p>
<p class="tbodyleft">&#x2193; Fibrinolytic activity</p>
<p class="tbodyleft">&#x2191; Homocysteine</p></td>
</tr>
</table>
<p class="tablesource"><em>Note:</em> Risk factors for first, unprovoked venous thromboembolism. Note that the factor levels that are increased are procoagulant proteins.</p>
<p class="tablesource">&#x2191;, increased; &#x2193;, decreased.</p>
<p class="tablesource">Adapted from Koupenova, M., Kehrel, B. E., Corkerey, H. A., &#x0026; Freedman, J. E. (2016). Thrombosis and platelets: An update. <em>European Heart Journal</em>, <em>38</em>(11), 785&#x2013;791.</p>
</div>
</section>
</div>
</body>
</html>